Direct Oral Anticoagulants in Patients With Active Cancer

Direct Oral Anticoagulants in Patients With Active Cancer

Background: Many patients with cancer have a hypercoagulable state and an increased risk of developing venous thromboembolism (VTE), arterial occlusion, and pulmonary emboli. Patients with cancer may also have an increased risk of bleeding with anticoagulant treatment. Recent trials have reported th...

Full description

Bibliographic Details
Main Authors: Jolanda Sabatino, MD, PhD, Salvatore De Rosa, MD, PhD, Alberto Polimeni, MD, PhD, Sabato Sorrentino, MD, PhD, Ciro Indolfi, MD
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:JACC. CardioOncology
Subjects:
cancer
direct oral anticoagulants
DOACs
hypercoagulable state
venous thromboembolism
Online Access:http://www.sciencedirect.com/science/article/pii/S2666087320301484

Internet

http://www.sciencedirect.com/science/article/pii/S2666087320301484

Similar Items